Literature DB >> 16558050

Immunosuppressive agents in intracellular infection: besnoitiosis in hamsters.

H R Wilson1, J K Frenkel.   

Abstract

When tested for their activity in suppressing the acquisition of immunity during acute Besnoitia infection of hamsters, antilymphocyte serum (ALS), aminopterin, cyclophosphamide, cortisol, and whole-body irradiation were the most active agents and effectively blocked the development of immunity during 4 to 12 days of immunization. Actinomycin D and chlorambucil were moderately active, and nitrogen mustard, 6-mercaptopurine, and vinblastine exhibited slight immunosuppressive activity. Established immunity was especially labile to cortisol and cortisone administration with generalized Besnoitia relapse occurring consistently in all hamsters; this occurred infrequently during cyclophosphamide treatment. Focal relapse was seen in chronically irradiated and ALS-treated hamsters, but the location of the lesions differed. Irradiated hamsters had lesions in the lungs and brain, whereas ALS-treated hamsters showed splenic relapse. Acquisition of immunity was more sensitive to suppression than established immunity and did not necessarily parallel antibody development and vice versa, emphasizing the importance of cellular over humoral factors in immunity to this intracellular parasite.

Entities:  

Year:  1971        PMID: 16558050      PMCID: PMC416233          DOI: 10.1128/iai.3.6.756-761.1971

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma).

Authors:  A B Sabin; H A Feldman
Journal:  Science       Date:  1948-12-10       Impact factor: 47.728

2.  Effects of antilymphocytic serum on host responses to infectious agents.

Authors:  M S Hirsch
Journal:  Fed Proc       Date:  1970 Jan-Feb

Review 3.  Review lecture. Immunosuppressive agents, with special reference to antilymphocytic serum.

Authors:  P Medawar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-11-18

4.  Adoptive immunity to intracellular infection.

Authors:  J K Frenkel
Journal:  J Immunol       Date:  1967-06       Impact factor: 5.422

5.  The clinical significance of cytomegalovirus infection in renal transplant recipients.

Authors:  D Rifkind; N Goodman; R B Hill
Journal:  Ann Intern Med       Date:  1967-06       Impact factor: 25.391

6.  Cytomegalovirus infection and cytomegalic inclusion disease in renal homotransplant recipients.

Authors:  R E Kanich; J E Craighead
Journal:  Am J Med       Date:  1966-06       Impact factor: 4.965

7.  Enhancing effect of antilymphocytic serum on mycobacterial infections in mice.

Authors:  J Gaugas; R J Rees
Journal:  Nature       Date:  1968-07-27       Impact factor: 49.962

8.  Enhancing effect of antilymphocytic globulin on human leprosy infection in thymectomized mice.

Authors:  J M Gaugas
Journal:  Nature       Date:  1968-12-21       Impact factor: 49.962

9.  Selective suppression of cellular immunity by antilymphocyte serum.

Authors:  E M Lance; J R Batchelor
Journal:  Transplantation       Date:  1968-05       Impact factor: 4.939

10.  Pneumocystis carinii pneumonia. Studies on the diagnosis and treatment.

Authors:  D Rifkind; T D Faris; R B Hill
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

View more
  5 in total

1.  Suppressor T cells and host resistance to tye 111 pneumococcus after treatment with antilymphocyte serum.

Authors:  R F Barth; O Singla; C Liu
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

2.  Animal model: chronic besnoitiosis of golden hamster (mesocricetus auratus).

Authors:  J K Frenkel
Journal:  Am J Pathol       Date:  1977-03       Impact factor: 4.307

3.  Biological nature of Cryptosporidium sp. isolated from a cat.

Authors:  H Asahi; T Koyama; H Arai; Y Funakoshi; H Yamaura; R Shirasaka; K Okutomi
Journal:  Parasitol Res       Date:  1991       Impact factor: 2.289

4.  Effect of antithymocyte serum on experimental toxoplasmosis in mice.

Authors:  O Strannegård; E Lycke
Journal:  Infect Immun       Date:  1972-05       Impact factor: 3.441

5.  Immune competence in a patient with Hodgkin's disease and relapsing toxoplasmosis.

Authors:  J K Frenkel; M Amare; W Larsen
Journal:  Infection       Date:  1978       Impact factor: 3.553

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.